End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30,350 KRW | -1.46% | -0.16% | -14.63% |
14/03 | JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
22/01 | CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions | MT |
Business Summary
Number of employees: 1,197
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 684,351 | 100.0 % | 748,527 | 100.0 % | +9.38% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 684,351 | 100.0 % | 748,527 | 100.0 % | +9.38% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Seong-Yeol Lee
CEO | Chief Executive Officer | 61 | - |
Yeong-Seob Shin
CEO | Chief Executive Officer | 61 | - |
Kyung-Ha Lee
CHM | Chairman | 60 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kyung-Ha Lee
CHM | Chairman | 60 | - |
Seong-Yeol Lee
CEO | Chief Executive Officer | 61 | - |
Gyu-Eon Jung
BRD | Director/Board Member | 62 | - |
Yeong-Seob Shin
CEO | Chief Executive Officer | 61 | - |
Yong-Gwan Kim
BRD | Director/Board Member | 56 | - |
Bi-Ho Jeon
BRD | Director/Board Member | 67 | 29/19/29 |
Jung-Hwan Han
BRD | Director/Board Member | 64 | 29/19/29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 341,871 | 187,476 ( 54.84 %) | 4,013 ( 1.174 %) | 52.98 % |
Stock B | 0 | 1,063,535 | 0 | 0 | |
Stock C | 1 | 23,280,123 | 13,000,887 ( 55.85 %) | 290,334 ( 1.247 %) | |
Stock D | 0 | 209,912 | 0 | 3,040 ( 1.448 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
4,093 | 1.20% | 93,033 $ |
Company contact information
Sector
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.63% | 522M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- A001060 Stock
- Company JW Pharmaceutical Corporation